Royal Bank Of Canada My Md Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.22 - $0.58 $2,472 - $6,517	-11,237 Reduced 97.87%	245 $0
Q3 2023 Nov 14, 2023	BUY	$0.47 - $1.87 $5,321 - $21,172	11,322 Added 7076.25%	11,482 $6,000
Q2 2023 Aug 14, 2023	SELL	$1.44 - $2.26 $1,314 - $2,063	-913 Reduced 85.09%	160 $0
Q1 2023 May 15, 2023	BUY	$1.1 - $2.86 $723 - $1,881	658 Added 158.55%	1,073 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.92 - $96.0 $1,744 - $182,016	-1,896 Reduced 82.04%	415 $0
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $5,130 - $189,964	2,311 New	2,311 $6,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $4.78 $1,170 - $2,796	-585 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.34 - $6.05 $217 - $393	65 Added 12.5%	585 $3,000
Q4 2021 Feb 14, 2022	SELL	$5.46 - $9.69 $2,238 - $3,972	-410 Reduced 44.09%	520 $3,000
Q3 2021 Nov 15, 2021	BUY	$4.64 - $7.94 $4,315 - $7,384	930 New	930 $7,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.